Major pharmaceutical companies, including GSK, Pfizer, Sanofi, and Boehringer Ingelheim, are seeking permission from a Delaware court to appeal a ruling that allows over 70,000 lawsuits claiming that the heartburn drug Zantac causes cancer to proceed. The companies argue against the admissibility of expert testimony linking Zantac to cancer.